Sinus Dilator Market worth 2.78 Billion USD by 2023
According to research report the global sinus dilator market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810
The
growth of the sinus dilator market can be attributed to the high
prevalence of chronic sinusitis, growing preference for minimally
invasive procedures, benefits of balloon sinuplasty/sinus dilation over
conventional sinus surgeries, and favorable reimbursement scenario for
sinus procedures in developed countries.
In 2018, North America
is expected to dominate the sinus dilator market followed by Europe. The
large share of this geographical segment is attributed to rapidly
increasing geriatric population, rising prevalence of chronic sinusitis,
higher adoption of new technologies among ENT surgeons and
otolaryngologists, favorable reimbursement scenario, and the presence of
major players in this region.
Based on patient care setting, the
ENT clinics/in office segment is projected to grow at the highest CAGR
during the forecast period
Based on patient care setting, the
sinus dilation devices market is segmented into hospitals, ambulatory
surgical centers, and ENT clinics/in office. The ENT clinics/in office
segment is expected to register the highest CAGR during the forecast
period. The growth of this segment can be attributed to increasing
number of treatable patients in ENT clinics, faster recovery time,
cost-effectiveness, and growing preference for minimally invasive
techniques.
Balloon sinus dilation devices segment is expected to dominate the market in 2018
Based
on product, the sinus dilation devices market is segmented into balloon
sinus dilation devices, endoscopes, sinus stents/implants, and handheld
instruments. The balloon sinus dilator market is further classified as
standalone and hybrid according to the type of procedure. In 2018,
balloon sinus dilation devices are expected to account for the largest
share of the global sinus dilation devices market. This large share can
be attributed to the rising prevalence of chronic sinusitis, increasing
preference for minimally invasive surgical procedures, and the
increasing focus of market players on launching advanced balloon sinus
dilation devices.
Key players in the sinus dilator market include
The major players in the market are Entellus Medical Inc. (a subsidiary
of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson &
Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK),
Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players
in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys
Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China)
and dalENT Medical (US). These players are increasingly undertaking
mergers and acquisitions, and product launches to develop and introduce
new technologies and products in the sinus dilation devices market.
Get Report Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=64349810
Comments
Post a Comment